Drug profile · INN
fenfluramine
FINTEPLA
fenfluramine (FINTEPLA) is a serotonin 2c (5-ht2c) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — fenfluramine
- US status
- approved
- Class
- Nervous system (N03)
- Route
- ORAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
fenfluramine (FINTEPLA) is a serotonin 2c (5-ht2c) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 2c (5-HT2c) receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is fenfluramine?
fenfluramine (FINTEPLA) is a serotonin 2c (5-ht2c) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fenfluramine?
FINTEPLA is a marketed brand name for fenfluramine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fenfluramine?
fenfluramine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.